Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
Holders of 5% or more of BNTC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Benitec Biopharma Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 13D/A | 44.10%17.8M shares | −5.80 ppfrom 49.90% | May 7, 20219 filings | Nov 10, 2025 | SEC |
| Franklin Resources Inc | 13G/A | 10.60%3.75M shares | −4.30 ppfrom 14.90% | Oct 11, 20228 filings | Jan 29, 2026 | SEC |
| Janus Henderson Group PLC | 13G/A | 9.99%3.38M shares | −1.31 ppfrom 11.30% | Aug 18, 202311 filings | Dec 8, 2025 | SEC |
| Ra Capital Management, L.P. | 13G | 5.50%1.85M shares | New | Dec 3, 20251 filing | Dec 3, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
58 Schedule 13D and 13G filings on Benitec Biopharma Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 14, 2021 | Oliveira Steven Michael | 13G/AOld format | – | – | – | SEC |
| Apr 12, 2021 | Morgan Stanley | 13G/AOld format | – | – | – | SEC |
| Apr 5, 2021 | Oliveira Steven Michael | 13GOld format | – | New | – | SEC |
| Mar 22, 2021 | Morgan Stanley | 13GOld format | – | New | – | SEC |
| Feb 12, 2021 | Packer Paul | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2021 | Hudson Bay Capital Management LP | 13GOld format | – | New | – | SEC |
| Jan 19, 2021 | Alpha Capital Anstalt | 13G/AOld format | – | – | – | SEC |
| Jan 8, 2021 | Sabby Management, LLC | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Benitec Biopharma Inc. shares.
No Form 144 notices for Benitec Biopharma Inc. are on file.